StemBioSys
VerifiedStemBioSys develops proprietary stem cell technologies for the regenerative medicine market.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$16—25m (Dealroom.co estimates May 2018.)
San Antonio Texas (HQ)
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
* | $50.0k | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about StemBioSys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.